Skip to main content
. 2018 Mar 28;30:317–325. doi: 10.1016/j.ebiom.2018.03.030

Fig. 1.

Fig. 1

SB ameliorates survival, weight loss, colon length, and disease activity index in the TNBS-induced mouse IBD model. WT and GPR109a−/− mice were pre-treated with SB for 6 weeks and then treated with TNBS for 6 days. (A) Survival of TNBS- and SB-treated WT and GPR109a−/−mice (n = 14). (B) Weight loss (the previous day's body weight – the day's body weight) in TNBS- and SB-treated WT and GPR109a−/−mice (n = 8–12). (C) Colon length in TNBS- and SB-treated WT and GPR109a−/− mice (n = 8–12). (D) Disease activity index of TNBS- and SB-treated WT and GPR109a−/−mice (n = 8–12).